African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2288

Full Length Research Paper

Pharmacokinetics of isoniazid in 30 tuberculosis patients in Abidjan, Côte d'Ivoire

Djadji A. T. L. *
  • Djadji A. T. L. *
  • Laboratory of Pharmacology and Clinical Pharmacy, Faculty of Pharmaceutical and Biological Sciences, Felix Houphouet Boigny?s University, Abidjan.
  • Search for this author on:
  • Google Scholar
Kouakou A. F.
  • Kouakou A. F.
  • Laboratory of Pharmacology and Clinical Pharmacy, Faculty of Pharmaceutical and Biological Sciences, Felix Houphouet Boigny?s University, Abidjan.
  • Search for this author on:
  • Google Scholar
Kamagate M.
  • Kamagate M.
  • Laboratory of Clinical Pharmacology, Faculty of Medicine Felix Houphouet Boigny?s University, Abidjan.
  • Search for this author on:
  • Google Scholar
Siransy-Kouakou G.
  • Siransy-Kouakou G.
  • Laboratory of Pharmacology and Clinical Pharmacy, Faculty of Pharmaceutical and Biological Sciences, Felix Houphouet Boigny?s University, Abidjan.
  • Search for this author on:
  • Google Scholar
Bekegnran C.
  • Bekegnran C.
  • Laboratory of Pharmacology and Clinical Pharmacy, Faculty of Pharmaceutical and Biological Sciences, Felix Houphouet Boigny?s University, Abidjan.
  • Search for this author on:
  • Google Scholar
Abrogoua D. P.
  • Abrogoua D. P.
  • Laboratory of Pharmacology and Clinical Pharmacy, Faculty of Pharmaceutical and Biological Sciences, Felix Houphouet Boigny?s University, Abidjan.
  • Search for this author on:
  • Google Scholar
Kablan B. J.
  • Kablan B. J.
  • Laboratory of Pharmacology and Clinical Pharmacy, Faculty of Pharmaceutical and Biological Sciences, Felix Houphouet Boigny?s University, Abidjan.
  • Search for this author on:
  • Google Scholar
Die-Kacou H.
  • Die-Kacou H.
  • Laboratory of Clinical Pharmacology, Faculty of Medicine Felix Houphouet Boigny?s University, Abidjan.
  • Search for this author on:
  • Google Scholar
Eholie S. P.
  • Eholie S. P.
  • Department of Infectious and Tropical Diseases, Faculty of medicine Felix Houphouet Boigny?s University, Abidjan.
  • Search for this author on:
  • Google Scholar
Garraffo R.
  • Garraffo R.
  • Department of Clinical Pharmacology and medical Toxicology, Hospital Pasteur, Nice France.
  • Search for this author on:
  • Google Scholar


  •  Received: 10 April 2014
  •  Accepted: 02 March 2015
  •  Published: 29 July 2015

Abstract

Isoniazid is a major component in tuberculosis (TB) treatment, which is often used in combination or alone as prophylaxis for its high efficiency on bacilli of Mycobacterium tuberculosis. It is responsible for an increased risk of developing serious liver side effects involving the prognosis of the patient. Its coinfection with HIV is currently a real public health problem. The purpose of this study was to establish the pharmacokinetic profile of isoniazid in Ivorian patients infected with TB taking a combination containing isoniazid at Abidjan. A cross-sectional analytical and descriptive study on the pharmacokinetics of isoniazid in 30 adults Ivorian patients on TB treatment was conducted. Blood samples at intervals of time were performed by high performance liquid chromatography-ultra violet (HPLC-UV). 30 adult patients were enrolled, with sex ratio M/F = 2. Mean age was 38.67 (18 to 67 years). 56 (7%) were slow acetylators. 14 (46.7%) were treated for pulmonary TB smear negative and 36.67% had a co-infection TB/HIV. A positive correlation was also observed between body mass index (BMI) and Vd (0.444 and p = 0.14) and a negative correlation between BMI and Tmax (-0.399, P = 0.29). The main biological variable influencing pharmacokinetic parameters according to the analysis is the acetylation profile of the patient.

Key words: Pharmacokinetics, Isoniazid (INH), tuberculosis, Abidjan.

Copyright © 2024 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 9 No. 28
Back to articles
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES